Source: Eur Respir J 2010; 36: 684-686



Rating:

Share or cite this content

Citations should be made in the following way:
Bakker J.A., Bierau J., Drent M.. A role for ITPA variants in the clinical course of pulmonary Langerhans' cell histiocytosis?. Eur Respir J 2010; 36: 684-686

Member's Comments

No comment yet.

Related content which might interest you: Langerhans' cell histiocytosis: clinical and diagnostic features and response to therapy Source: Eur Respir J 2001; 18: Suppl. 33, 219s Year: 2001 Clinical impact of BRAFV600E mutation in adult pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases Year: 2019 Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Langerhans cell histiocytosis: is it an ILD? Source: Virtual Congress 2021 – Interstitial lung diseases Year: 2021 Pulmonary Langerhans' cell histiocytosis Source: Eur Respir Mon; 2009: 46: 155–175 Year: 2009 Genetic landscape of adult Langerhans cell histiocytosis with lung involvement Source: Eur Respir J, 55 (2) 1901190; 10.1183/13993003.01190-2019 Year: 2020 How I manage pulmonary Langerhans cell histiocytosis Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017 Year: 2017 Exercise in patients with pulmonary Langerhans cell histiocytosis: performance and mechanisms of limitation Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017 Genetic studies yield clues to the pathogenesis of Langerhans cell histiocytosis Source: Eur Respir J 2016; 47:1629-1631 Year: 2016 Genetic landscape of pulmonary langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Pulmonary Langerhans' cell histiocytosis Source: Respipedia Article Year: 2016 Pulmonary Langerhans histiocytosis: clinical, radiological and functional pattern in spontaneous remission Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Chemotherapy in patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Do high resolution CT findings predict lung function impairment in pulmonary Langerhans cell histiocytosis? Source: Eur Respir J 2002; 20: Suppl. 38, 59s Year: 2002 Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Lack of evidence for the involvement of Merkel cell polyomavirus in pulmonary Langerhans cell histiocytosis Source: ERJ Open Res, 6 (2) 00230-2019; 10.1183/23120541.00230-2019 Year: 2020 Paediatric pulmonary Langerhans cell histiocytosis Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020 Year: 2020 Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis Source: Eur Respir J 2016; 47:1785-1796 Year: 2016 Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019